Intestinal glucose stimulation has anti-incretin effect

September 13, 2017

(HealthDay)—Intestinal glucose stimulation has an anti-incretin effect, down regulating insulin sensitivity, according to a study published online Aug. 29 in Diabetes.

Serenella Salinari, D.Sc., from the University of Rome "La Sapienza," and colleagues studied eight healthy volunteers and eight severely obese individuals with insulin resistance. After test and isoglycemic intravenous glucose injection, the authors measured , insulin sensitivity, rate of glucose appearance, and disposition index. Obese individuals were assessed before and after intestinal bypass (biliopancreatic diversion [BPD]).

The researchers found that insulin sensitivity was lower during oral versus intravenous glucose administration, despite isoglycemic conditions. The difference was greater in obese subjects, and declined to normal following BPD. No evidence was found for glucose malabsorption. If was not reduced by oral glucose stimulation, mathematical simulations showed that hypoglycemia would occur.

"The findings support a new model for how foodborne factors can induce insulin-resistance and provide a possible explanation for the improvement of insulin resistance/diabetes after gastrointestinal bypass surgery," the authors write.

Explore further: Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Adipose tissue insulin resistance up in obese-NGT, IGT, T2DM

January 9, 2017
(HealthDay)—Resistance to the antilipolytic effect of insulin (Adipo-IR) is increased in obese individuals with normal glucose tolerance (NGT), and in those with impaired glucose tolerance (IGT) and type 2 diabetes (T2DM), ...

Progression of dysglycemia in youth similar to adults

July 12, 2014
(HealthDay)—For obese adolescents, glucose sensitivity deteriorates progressively across the spectrum of glucose tolerance, according to a study published online June 19 in Diabetes.

Metabolic benefit same with similar weight loss after surgery

November 21, 2016
(HealthDay)—Early metabolic differences following laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) in obese individuals with type 2 diabetes mellitus (T2DM) disappear when weight loss reaches ...

L. reuteri enrichment of gut microbiota ups insulin secretion

October 12, 2015
(HealthDay)—Enrichment of gut microbiota with Lactobacillus reuteri is associated with increased insulin secretion, according to a study published in the October issue of Diabetes Care.

Hypothalamic Lin28a shows role in glucose homeostasis

June 5, 2017
(HealthDay)—An experimental study supports a TANK-binding kinase 1 (TBK-1)-dependent role for Lin28a in the hypothalamic ventromedial nucleus in glucose homeostasis. The study was published online May 26 in Diabetes.

SFRP4 linked to impaired glucose tolerance, T2DM

August 1, 2016
(HealthDay)—Secreted frizzled-related protein 4 (SFRP4) is associated with impaired glucose tolerance (IGT) and type 2 diabetes (T2D), according to a report published online July 6 in Diabetes Care.

Recommended for you

Scientists reverse diabetes in a mouse model using modified blood stem cells

November 15, 2017
Researchers at Boston Children's Hospital have successfully reversed type 1 diabetes in a mouse model by infusing blood stem cells pre-treated to produce more of a protein called PD-L1, which is deficient in mice (and people) ...

Pregnancy-related conditions taken together leave moms—and dads—at risk

November 14, 2017
Research has already shown that women who develop either diabetes or high blood pressure during pregnancy are at risk of getting type 2 diabetes, high blood pressure or heart disease years later. Now, a new study from a team ...

Study reveals how a very low calorie diet can reverse type 2 diabetes

November 9, 2017
In a new study, a Yale-led research team uncovers how a very low calorie diet can rapidly reverse type 2 diabetes in animal models. If confirmed in people, the insight provides potential new drug targets for treating this ...

Targeting a microRNA shows potential to enhance effectiveness of diabetes drugs

November 7, 2017
Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes.

Researchers link Western diet to vascular damage and prediabetes

October 31, 2017
Could short-term exposure to the average American diet increase one's risk for developing diabetes and cardiovascular disease? According to a recent study funded by the American Heart Association (AHA), researchers from New ...

Researchers design synthetic beta cells to secrete insulin in response to high blood sugar

October 30, 2017
Treating type 1 diabetes and some cases of type 2 diabetes has long required painful and frequent insulin injections or a mechanical insulin pump for insulin infusion. But researchers from the University of North Carolina ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.